These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 37442952)

  • 1. The representative COVID-19 cohort Munich (KoCo19): from the beginning of the pandemic to the Delta virus variant.
    Le Gleut R; Plank M; Pütz P; Radon K; Bakuli A; Rubio-Acero R; Paunovic I; Rieß F; Winter S; Reinkemeyer C; Schälte Y; Olbrich L; Hannes M; Kroidl I; Noreña I; Janke C; Wieser A; Hoelscher M; Fuchs C; Castelletti N;
    BMC Infect Dis; 2023 Jul; 23(1):466. PubMed ID: 37442952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From first to second wave: follow-up of the prospective COVID-19 cohort (KoCo19) in Munich (Germany).
    Radon K; Bakuli A; Pütz P; Le Gleut R; Guggenbuehl Noller JM; Olbrich L; Saathoff E; Garí M; Schälte Y; Frahnow T; Wölfel R; Pritsch M; Rothe C; Pletschette M; Rubio-Acero R; Beyerl J; Metaxa D; Forster F; Thiel V; Castelletti N; Rieß F; Diefenbach MN; Fröschl G; Bruger J; Winter S; Frese J; Puchinger K; Brand I; Kroidl I; Wieser A; Hoelscher M; Hasenauer J; Fuchs C;
    BMC Infect Dis; 2021 Sep; 21(1):925. PubMed ID: 34493217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Prospective COVID-19 Post-Immunization Serological Cohort in Munich (KoCo-Impf): Risk Factors and Determinants of Immune Response in Healthcare Workers.
    Reinkemeyer C; Khazaei Y; Weigert M; Hannes M; Le Gleut R; Plank M; Winter S; Noreña I; Meier T; Xu L; Rubio-Acero R; Wiegrebe S; Le Thi TG; Fuchs C; Radon K; Paunovic I; Janke C; Wieser A; Küchenhoff H; Hoelscher M; Castelletti N;
    Viruses; 2023 Jul; 15(7):. PubMed ID: 37515259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and Risk Factors of Infection in the Representative COVID-19 Cohort Munich.
    Pritsch M; Radon K; Bakuli A; Le Gleut R; Olbrich L; Guggenbüehl Noller JM; Saathoff E; Castelletti N; Garí M; Pütz P; Schälte Y; Frahnow T; Wölfel R; Rothe C; Pletschette M; Metaxa D; Forster F; Thiel V; Rieß F; Diefenbach MN; Fröschl G; Bruger J; Winter S; Frese J; Puchinger K; Brand I; Kroidl I; Hasenauer J; Fuchs C; Wieser A; Hoelscher M; On Behalf Of The KoCo Study Group
    Int J Environ Res Public Health; 2021 Mar; 18(7):. PubMed ID: 33808249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Dried Blood Spot protocol for high-throughput quantitative analysis of SARS-CoV-2 RBD serology based on the Roche Elecsys system.
    Castelletti N; Paunovic I; Rubio-Acero R; Beyerl J; Plank M; Reinkemeyer C; Kroidl I; Noreña I; Winter S; Olbrich L; Janke C; Hoelscher M; Wieser A;
    Microbiol Spectr; 2024 Apr; 12(4):e0288523. PubMed ID: 38426747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 Infection-and mRNA Vaccine-induced Humoral Immunity among Schoolchildren in Hawassa, Ethiopia.
    Merid Y; Tekleselasie W; Tesfaye E; Gadisa A; Fentahun D; Abate A; Alemu A; Mihret A; Mulu A; Gelanew T
    Front Immunol; 2023; 14():1163688. PubMed ID: 37398668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 Cases and Hospitalizations by COVID-19 Vaccination Status and Previous COVID-19 Diagnosis - California and New York, May-November 2021.
    León TM; Dorabawila V; Nelson L; Lutterloh E; Bauer UE; Backenson B; Bassett MT; Henry H; Bregman B; Midgley CM; Myers JF; Plumb ID; Reese HE; Zhao R; Briggs-Hagen M; Hoefer D; Watt JP; Silk BJ; Jain S; Rosenberg ES
    MMWR Morb Mortal Wkly Rep; 2022 Jan; 71(4):125-131. PubMed ID: 35085222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disease severity and efficacy of homologous vaccination among patients infected with SARS-CoV-2 Delta or Omicron VOCs, compared to unvaccinated using main biomarkers.
    Ali AM; Tofiq AM; Rostam HM; Ali KM; Tawfeeq HM
    J Med Virol; 2022 Dec; 94(12):5867-5876. PubMed ID: 36029103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of BNT162b2 and CoronaVac COVID-19 vaccination against asymptomatic and symptomatic infection of SARS-CoV-2 omicron BA.2 in Hong Kong: a prospective cohort study.
    Tsang NNY; So HC; Cowling BJ; Leung GM; Ip DKM
    Lancet Infect Dis; 2023 Apr; 23(4):421-434. PubMed ID: 36521506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the Roche SARS-CoV-2 Rapid Antibody Test in Samples from Vaccinated Individuals.
    Hayer J; Urlaub E
    Microbiol Spectr; 2022 Jun; 10(3):e0270921. PubMed ID: 35575594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistence and Protective Potential of SARS-CoV-2 Antibody Levels After COVID-19 Vaccination in a West Virginia Nursing Home Cohort.
    Smoot K; Yang J; Tacker DH; Welch S; Khodaverdi M; Kimble W; Wen S; Amjad A; Marsh C; Perrotta PL; Hodder S
    JAMA Netw Open; 2022 Sep; 5(9):e2231334. PubMed ID: 36098966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 pandemic dynamics in India, the SARS-CoV-2 Delta variant, and implications for vaccination.
    Yang W; Shaman J
    medRxiv; 2021 Nov; ():. PubMed ID: 34845460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccine effectiveness against SARS-CoV-2 infection or COVID-19 hospitalization with the Alpha, Delta, or Omicron SARS-CoV-2 variant: A nationwide Danish cohort study.
    Gram MA; Emborg HD; Schelde AB; Friis NU; Nielsen KF; Moustsen-Helms IR; Legarth R; Lam JUH; Chaine M; Malik AZ; Rasmussen M; Fonager J; Sieber RN; Stegger M; Ethelberg S; Valentiner-Branth P; Hansen CH
    PLoS Med; 2022 Sep; 19(9):e1003992. PubMed ID: 36048766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breakthrough SARS-CoV-2 infections after COVID-19 mRNA vaccination in MS patients on disease modifying therapies during the Delta and the Omicron waves in Italy.
    Sormani MP; Schiavetti I; Inglese M; Carmisciano L; Laroni A; Lapucci C; Visconti V; Serrati C; Gandoglia I; Tassinari T; Perego G; Brichetto G; Gazzola P; Mannironi A; Stromillo ML; Cordioli C; Landi D; Clerico M; Signoriello E; Cocco E; Frau J; Ferrò MT; Di Sapio A; Pasquali L; Ulivelli M; Marinelli F; Pizzorno M; Callari G; Iodice R; Liberatore G; Caleri F; Repice AM; Cordera S; Battaglia MA; Salvetti M; Franciotta D; Uccelli A;
    EBioMedicine; 2022 Jun; 80():104042. PubMed ID: 35526306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Community risks for SARS-CoV-2 infection among fully vaccinated US adults by rurality: A retrospective cohort study from the National COVID Cohort Collaborative.
    Anzalone AJ; Sun J; Vinson AJ; Beasley WH; Hillegass WB; Murray K; Hendricks BM; Haendel M; Geary CR; Bailey KL; Hanson CK; Miele L; Horswell R; McMurry JA; Porterfield JZ; Vest MT; Bunnell HT; Harper JR; Price BS; Santangelo SL; Rosen CJ; McClay JC; Hodder SL;
    PLoS One; 2023; 18(1):e0279968. PubMed ID: 36603014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seroprevalence of Unidentified SARS-CoV-2 Infection in Hong Kong During 3 Pandemic Waves.
    Boon SS; Wong MCS; Ng RWY; Leung DTM; Chen Z; Lai CKC; Ho WCS; Huang J; Wong BKC; Fung KSC; Chan PKS
    JAMA Netw Open; 2021 Nov; 4(11):e2132923. PubMed ID: 34779848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protocol of a population-based prospective COVID-19 cohort study Munich, Germany (KoCo19).
    Radon K; Saathoff E; Pritsch M; Guggenbühl Noller JM; Kroidl I; Olbrich L; Thiel V; Diefenbach M; Riess F; Forster F; Theis F; Wieser A; Hoelscher M;
    BMC Public Health; 2020 Jun; 20(1):1036. PubMed ID: 32605549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [COVID-19 infections and effectiveness of the vaccination among healthcare workers].
    Rojkovich B; Németh D; Dinya E; Nagy E; Török E; Lázár I; Perduk A; Géher P; Nagy G
    Orv Hetil; 2023 Feb; 164(5):163-171. PubMed ID: 36739547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.